RGS5 and metabolic dysfunction-associated steatohepatitis: As shown in Figure 7B, similar expression profiles of RGS5 were observed in the data from the WB analysis, and STAT3 and NF-κB phosphorylation were also markedly upregulated in NASH livers and significantly attenuated by resmetirom.